The problem we solve: In response to the ongoing global COVID-19 pandemic, PhenoMx has created the PhenoCHEST (TM) rapid CT screening protocol. This new tool leverages non-invasive CT scanning, digital chest X-Rays and start-of-the-art Artificial Intelligence algorithms to rapidly score findings and characteristics associated with the presence of COVID-19. PhenoCHEST (TM) has been developed using a limited real-world data set from patients infected with COVID-19 in both China and South Korea.
About our solution: Our image processing platform helps screen & triage suspected cases from the time of onset of symptoms to the reporting of results from PCT testing, limiting the exposure and transmission to other people. For example, when a patient develops fever, cough, etc, they can be arrive at an imaging facility, even separate from the hospital, to be scanned and receive a result in under 2 minutes, compared with arriving at a crowded ER/Urgent Care facility with the possibility of infecting or becoming infected via other while waiting for a PCR test, and then waiting days for a result. During the crisis in China they were scanning on average 200 people per day per scanner (approx every 5-7 minutes).Progress to date:
Dialogue with FDA & FEMA yesterday and the Spanish Government today. Currently involved in a clinical trial in Korea (executed data sharing agreement, IRB submission, protocol, and MOU). In discussions with Germany, India, Italy, Spain, Thailand, UAE, and USA.
Creator: Digital Health
Location: New York
Bio: We Improve Lives, Transforming Medicine Along the Way
Advanced Degree(s): MD
No updates found .
Help us find best new ideas to fund by telling us what you think. Your feedback goes straight to the team behind this project in private, so tell them what you really think.